| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.4 | 4e-08 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.38 | 7e-08 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.37 | 1e-07 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0002 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |